Nina Capital

Sonar is a healthcare company focusing on the proactive identification and intervention of mental health challenges in youth.

Connective Health offers a digital health platform that provides clinical-grade summaries of patients' electronic health records (EHR), along with real-time insights. This system consolidates patient history, findings, medications, diagnoses, and behavioral care information to assist healthcare providers in saving time and delivering accurate treatment.

Selfii is a healthcare technology company that operates a data collection platform. It aggregates and structures patient-consented healthcare data from various sources like electronic health records and patient-generated data. This data is then transformed into a comprehensive medical knowledge graph, enabling researchers and healthcare professionals to accelerate clinical research, AI development, and app creation.

Noah Labs develops innovative technology aimed at the early detection of cardiovascular diseases through voice analysis. Utilizing advanced machine learning software, the company has created a digital health platform that allows patients to record their voices using a smartphone. This platform incorporates patient monitoring and digital biomarkers, providing personalized and predictive virtual care in the comfort of their homes. By focusing on voice-based diagnostics, Noah Labs seeks to empower individuals with cardiovascular conditions to lead healthier and longer lives.

Ryver specializes in developing software solutions for data collaboration and sharing while prioritizing privacy. The company's platform enables clients to generate synthetic data from original datasets efficiently, particularly in the medical field, where it facilitates the rapid access to radiology cases. By automating the evaluation of privacy and utility of synthetic data, Ryver eliminates the need for manual compliance processes, significantly reducing the time and cost associated with data acquisition. Their technology seamlessly integrates into various data warehouses, cloud environments, and IT infrastructures, thereby providing detailed compliance and usage information. This innovative approach supports medical AI teams in creating high-quality radiology images with annotations, enhancing both speed and effectiveness in medical data utilization.

Lillian is building a nationwide network of health facilities in Germany.

Alfie Health is a virtual obesity management clinic that focuses on sustainable weight loss through a combination of precision medicine and behavioral change. Utilizing proprietary AI clinical decision support technology, Alfie Health continuously analyzes patient data, including medication history and metabolic information, to tailor individualized weight management plans. The platform also offers regular telehealth visits, ensuring ongoing medical supervision and support for users. Additionally, patients are connected with certified health coaches who assist in determining the most effective medication combinations to achieve their weight loss goals. This innovative approach aims to provide comprehensive care from the convenience of patients' homes.

Hypercare develops a healthcare coordination platform designed to improve clinical communication and collaboration across departments and specialties. The platform provides secure messaging for clinicians, the ability to share images, videos, and documents, and on-call scheduling to manage shifts and bolster emergency response times. By replacing insecure consumer apps and fragmented paging systems, Hypercare aims to reduce delays, mitigate liability related to patient information, and enhance operational efficiency and patient outcomes for healthcare professionals.

Ryver specializes in developing software solutions for data collaboration and sharing while prioritizing privacy. The company's platform enables clients to generate synthetic data from original datasets efficiently, particularly in the medical field, where it facilitates the rapid access to radiology cases. By automating the evaluation of privacy and utility of synthetic data, Ryver eliminates the need for manual compliance processes, significantly reducing the time and cost associated with data acquisition. Their technology seamlessly integrates into various data warehouses, cloud environments, and IT infrastructures, thereby providing detailed compliance and usage information. This innovative approach supports medical AI teams in creating high-quality radiology images with annotations, enhancing both speed and effectiveness in medical data utilization.

Leuko Labs, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in the development of healthcare equipment. The company's primary product, PointCheck, is a non-invasive device designed to monitor and count white blood cells. This innovative technology allows for more frequent testing of immunosuppressed patients, such as those undergoing chemotherapy, enhancing their quality of life and clinical outcomes. The device is particularly beneficial as it eliminates the need for invasive blood draws and laboratory infrastructure, making it more accessible and convenient for patients.

Healee is a health tech company that provides a configurable telehealth platform for digital health innovators to deploy virtual care models. Its platform enables a fully branded patient experience and supports end-to-end clinical workflows, including telehealth visits, digital check-in and scheduling, while consolidating tools to reduce digital fatigue and align with electronic health records, e-prescribing and billing systems. The system also supports patient-doctor communication, health status tracking and sharing, and virtual consultations to help healthcare providers deliver efficient care and improve patient access.

Formulator is a mental healthcare platform designed to streamline the case formulation process for mental health professionals and their clients. By providing a structured tool, the platform enables individuals to articulate their situations and goals, facilitating effective communication with their clinicians from the outset. This approach enhances the productivity and accessibility of mental health care, allowing healthcare providers to address patients' core issues more efficiently. Formulator aims to simplify the initial steps of therapy, ultimately supporting better outcomes for clients and clinicians alike.

Elypta develops a liquid biopsy platform using metabolism-based biomarkers and artificial intelligence. Its platform measures glycosaminoglycan metabolites in blood and urine, aiming to enable earlier detection and monitoring of various cancer types.

Alfie Health is a virtual obesity management clinic that focuses on sustainable weight loss through a combination of precision medicine and behavioral change. Utilizing proprietary AI clinical decision support technology, Alfie Health continuously analyzes patient data, including medication history and metabolic information, to tailor individualized weight management plans. The platform also offers regular telehealth visits, ensuring ongoing medical supervision and support for users. Additionally, patients are connected with certified health coaches who assist in determining the most effective medication combinations to achieve their weight loss goals. This innovative approach aims to provide comprehensive care from the convenience of patients' homes.

Alfie Health is a virtual obesity management clinic that focuses on sustainable weight loss through a combination of precision medicine and behavioral change. Utilizing proprietary AI clinical decision support technology, Alfie Health continuously analyzes patient data, including medication history and metabolic information, to tailor individualized weight management plans. The platform also offers regular telehealth visits, ensuring ongoing medical supervision and support for users. Additionally, patients are connected with certified health coaches who assist in determining the most effective medication combinations to achieve their weight loss goals. This innovative approach aims to provide comprehensive care from the convenience of patients' homes.

Cardiomatics develops a cloud-based AI system for analyzing ECG data. Its platform uses validated algorithms to deliver accurate cardiac diagnostics, collaborating globally with physicians and ECG device manufacturers.

Promptly is a health data analytics company that collects, integrates, and analyzes care outcome data. It develops proprietary technology for patient engagement, real-world data collection, and outcomes analytics to discover digital biomarkers. Promptly partners with healthcare organizations to improve patient care and reduce costs.

EarlySight, a Lausanne-based medical device company, develops technology to detect and treat eye diseases at an early stage. Its flagship work includes a fundus camera that images the retina with high detail by combining eye illumination with real time ocular aberration correction. The company also leverages cellular level imaging and transscleral illumination to monitor day to day treatment effects in a non invasive manner, enabling eye specialists to visualize the morphology of retinal cells. Founded in 2016, EarlySight aims to bring its imaging technology to clinics to improve early diagnosis and treatment of ocular conditions.

contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.

Replica Analytics Ltd. is a Canadian company based in Ottawa that specializes in developing modeling software to create synthetic data derived from real clinical datasets. Founded in 2019, the company employs advanced machine learning technologies to generate privacy-protective synthetic data that retains the statistical properties of the original data. This platform not only facilitates the creation of high-utility synthetic datasets but also provides documentation regarding the utility characteristics of the data. By doing so, Replica Analytics enables businesses to access valuable data while adhering to global regulatory requirements for privacy protection and data analysis.

PlenOptika, Inc. is a technology company based in Allston, Massachusetts, that specializes in the development of a handheld device called QuickSee, which provides accurate eyeglass prescriptions through precise refractive measurements. Founded in 2014 as a spin-off from the Massachusetts Institute of Technology, the company addresses the significant global issue of low vision affecting over one billion people. QuickSee is designed to facilitate optometry, especially in rural and resource-limited settings, by simplifying the process of vision correction. The device captures the eye's full aberration fingerprint, effectively reducing the costs and physical space required by traditional autorefractors. PlenOptika aims to make eye care accessible to underserved communities worldwide and has received recognition from various social innovation foundations and business competitions for its contributions to healthcare technology.

Subtle Medical is a healthcare technology company that develops artificial‑intelligence software for magnetic resonance and positron emission tomography imaging. Its flagship products, SubtleMR and SubtlePET, are FDA‑cleared and CE‑marked tools that enhance image quality by reducing noise and sharpening detail, allowing scans to be performed faster and with lower radiation or contrast dose. The company’s deep‑learning algorithms integrate with any scanner without changing existing workflows, enabling imaging centers and hospitals to increase throughput and improve patient safety. Subtle Medical also offers a vendor‑agnostic AI platform that delivers analytics and support to clinical imaging providers. Founded in 2017 and headquartered in Menlo Park, California, the firm has received an NIH SBIR grant and an RSNA award for its GAD technology.

EarlySight, a Lausanne-based medical device company, develops technology to detect and treat eye diseases at an early stage. Its flagship work includes a fundus camera that images the retina with high detail by combining eye illumination with real time ocular aberration correction. The company also leverages cellular level imaging and transscleral illumination to monitor day to day treatment effects in a non invasive manner, enabling eye specialists to visualize the morphology of retinal cells. Founded in 2016, EarlySight aims to bring its imaging technology to clinics to improve early diagnosis and treatment of ocular conditions.

Ultromics Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in developing advanced echocardiography software aimed at enhancing the diagnosis of coronary heart disease. By leveraging artificial intelligence, the company has created highly accurate diagnostic tools that improve the identification of coronary artery disease, achieving diagnostic accuracy improvements of over 90%. Ultromics' technology processes complex data from electrocardiograms, empowering healthcare providers to make informed clinical decisions and ultimately enhancing patient care in cardiology.

contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.

Neurescue ApS, headquartered in Copenhagen, Denmark, specializes in developing innovative medical devices aimed at addressing cardiac arrest and hemorrhage. Established in 2014, the company has introduced its flagship product, the safeREBOA device, which is recognized as the first computer-aided aortic occlusion catheter designed to enhance the care of emergency patients. Neurescue's commitment lies in improving resuscitation rates and extending critical treatment time through advanced cardiovascular solutions. The organization is focused on advancing the clinical utility of its devices to ultimately save lives in emergency situations.

Elypta develops a liquid biopsy platform using metabolism-based biomarkers and artificial intelligence. Its platform measures glycosaminoglycan metabolites in blood and urine, aiming to enable earlier detection and monitoring of various cancer types.

PlenOptika, Inc. is a technology company based in Allston, Massachusetts, that specializes in the development of a handheld device called QuickSee, which provides accurate eyeglass prescriptions through precise refractive measurements. Founded in 2014 as a spin-off from the Massachusetts Institute of Technology, the company addresses the significant global issue of low vision affecting over one billion people. QuickSee is designed to facilitate optometry, especially in rural and resource-limited settings, by simplifying the process of vision correction. The device captures the eye's full aberration fingerprint, effectively reducing the costs and physical space required by traditional autorefractors. PlenOptika aims to make eye care accessible to underserved communities worldwide and has received recognition from various social innovation foundations and business competitions for its contributions to healthcare technology.

contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.

MindPeak GmbH is a technology company based in Hamburg, Germany, founded in 2018. It specializes in developing artificial intelligence software tools aimed at enhancing the accuracy and efficiency of cancer diagnostics. The company's flagship product, BreastAI, is designed for the quantification of breast cancer immunohistochemistry (IHC) and can be integrated into third-party software systems. MindPeak's solutions automate tissue diagnostics, enabling pathologists to identify and quantify tumorous regions and detect breast cancer cells more effectively. By streamlining tasks such as cell and biomarker quantification, MindPeak's tools allow cancer specialists to focus on critical decision-making in clinical environments, ultimately improving patient care while making diagnostic processes more accessible and cost-effective.

Leuko Labs, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in the development of healthcare equipment. The company's primary product, PointCheck, is a non-invasive device designed to monitor and count white blood cells. This innovative technology allows for more frequent testing of immunosuppressed patients, such as those undergoing chemotherapy, enhancing their quality of life and clinical outcomes. The device is particularly beneficial as it eliminates the need for invasive blood draws and laboratory infrastructure, making it more accessible and convenient for patients.